NEW YORK, Aug. 9, 2023 /PRNewswire/ — The spinal implants and surgical units market is estimated to develop at a CAGR of 5.3% between 2022 and 2027. The market measurement is forecasted to extend by USD 3,394.36 million, in accordance with Technavio. – Request a pattern report
Spinal Implants and Surgical Units Market Insights –
- Corporations: 15+, Together with Abbott Laboratories, Alphatec Holdings Inc., B. Braun Melsungen AG, Bioventus LLC, Boston Scientific Corp., Exactech Inc., Globus Medical Inc., Implanet SA, Integra Lifesciences Holdings Corp., Johnson and Johnson Providers Inc., Kuros Biosciences AG, Medtronic Plc, Nuvasive Inc., Orthofix Medical Inc., RTI Surgical Inc., Backbone Wave Inc., Spineart SA, Stryker Corp., ulrich GmbH and Co. KG, and Xtant Medical Inc., amongst others
- Protection: Mum or dad market evaluation; key drivers, main tendencies, and challenges; buyer and firm panorama; firm product insights and up to date developments; key firms; and market positioning of firms
- Segments: sort (open surgical procedures and minimally invasive surgical procedures), end-user (hospitals, ambulatory surgical facilities, and specialty clinics), and geography (North America, Europe, Asia, and the Remainder of World (ROW))
To grasp extra in regards to the spinal implants and surgical units market, request a pattern report
Spinal Implants and Surgical Units Market – Firm Insights
The rising competitors available in the market is compelling firms to undertake varied progress methods similar to promotional actions and spending on commercials to enhance the visibility of their providers. Technavio report analyzes the market’s aggressive panorama and gives data on a number of market firms together with – Abbott Laboratories, Alphatec Holdings Inc., B. Braun Melsungen AG, Bioventus LLC, Boston Scientific Corp., Exactech Inc., Globus Medical Inc., Implanet SA, Integra Lifesciences Holdings Corp., Johnson and Johnson Providers Inc., Kuros Biosciences AG, Medtronic Plc, Nuvasive Inc., Orthofix Medical Inc., RTI Surgical Inc., Backbone Wave Inc., Spineart SA, Stryker Corp., ulrich GmbH and Co. KG, and Xtant Medical Inc.
Spinal Implants and Surgical Units Market – Market Dynamics
Key Drivers
The growing prevalence of spinal problems is a key issue driving market progress. Frequent spinal illnesses similar to degenerative disc illness, spinal stenosis, and disc herniation have gotten more and more prevalent as a consequence of an growing older inhabitants, leading to elevated demand for spinal surgical procedure and implants. Degenerative illnesses similar to arthrosis and degenerative disc illness are significantly widespread with growing older, inflicting spinal ache and useful limitations.
This will increase the necessity for spinal implants and surgical devices. Moreover, a sedentary life-style negatively impacts spinal well being, leading to poor posture, weak again muscular tissues, elevated stress on the spine, and signs similar to decrease again ache, disc herniation, and spinal stenosis. This could additionally trigger medical societies and system producers to actively increase consciousness of those spinal problems by means of academic applications and conferences. Therefore, weak, or lacking MRO processes are anticipated to limit market progress throughout the forecast interval.
Main Traits
Technological developments is a significant pattern available in the market. Minimally invasive surgical methods, robotic surgical procedure, 3D printing of implants, superior imaging methods, and the event of biocompatible supplies for implants are a number of the current technological advances available in the market. As well as, these improvements purpose to enhance surgical outcomes, scale back affected person restoration time, and enhance the general high quality of spine surgical procedure. Titanium alloys and polyetheretherketone (PEEK) are among the many superior supplies for implants, providing good mechanical properties and compatibility with the human physique. Moreover, the minimally invasive method requires smaller incisions, decreasing tissue injury and shortening affected person restoration time. Ongoing analysis at varied universities is exploring the potential of his 3D printing in spine surgical procedure. Therefore, technological developments are anticipated to drive market progress throughout the forecast interval.
Important Challenges
The dangers related to interventional spine procedures are one of many important challenges limiting the market progress. Sufferers, particularly in growing nations, could also be reluctant to bear spinal interventions as a consequence of issues about attainable dangers. Some sufferers could select to not bear vertebroplasty due to the chance of cement leakage.
As well as, surgical procedure can shrink the vertebrae, growing the chance of future fractures. Necessary early penalties of vertebral fractures embrace laceration and leakage of additional vertebral polymethylmethacrylate (PMMA) cement by means of the venous system, which may result in spinal stenosis and pulmonary cement embolism. As well as, systemic allergic reactions, hematomas, or cement toxicity reactions pose important dangers throughout spinal intervention procedures. Therefore, dangers related to interventional spine procedures are anticipated to limit market progress throughout the forecast interval.
Drivers, Traits & Challenges have an effect on market dynamics and might influence companies. Discover some insights from a pattern report!
The spinal implants and surgical units market report offers vital data and factual information, with a qualitative and quantitative examine of the market primarily based on market drivers and limitations in addition to prospects.
Why Purchase?
- Add credibility to the technique
- Analyzes competitor’s choices.
- Get a holistic view of the market
- Develop your revenue margin with Technavio– Purchase the Report
What are the important thing information lined on this Spinal Implants and Surgical Units Market report?
- CAGR of the market throughout the forecast interval
- Detailed data on components that may drive the expansion of the spinal implants and surgical units market between 2023 and 2027
- Exact estimation of the dimensions of the spinal implants and surgical units market and its contribution to the market with a deal with the mum or dad market
- Correct predictions about upcoming tendencies and modifications in client conduct
- Development of the spinal implants and surgical units market throughout North America, Europe, Asia, and the Remainder of the World (ROW)
- An intensive evaluation of the market’s aggressive panorama and detailed details about firms
- Complete evaluation of things that may problem the expansion of spinal implants and surgical units market firms
Acquire on the spot entry to 17,000+ market analysis experiences.
Technavio’s SUBSCRIPTION platform
Associated Studies
The elastomeric infusion pumps market is estimated to develop by USD 800.97 million at a CAGR of seven.07% between 2022 and 2027. Moreover, this report extensively covers market segmentation by software (ache administration, antibiotic or antiviral, chemotherapy, and others), end-user (hospitals, ambulatory service facilities, clinics, and others), and geography (APAC, North America, Europe, Center East and Africa, and South America). The excessive demand for superior infusion pumps is a significant pattern available in the market.
The neuromodulation market is estimated to develop by USD 5,332.29 million at a CAGR of 12.02% between 2022 and 2027. Moreover, this report extensively covers market segmentation by product (implantable neuromodulation units and exterior neuromodulation units) end-user (hospitals, ASCS, and others), and geography (APAC, North America, Europe, Center East and Africa, and South America). The increasing purposes of neuromodulation therapies is a significant pattern available in the market.
Spinal Implants and Surgical Units Market Scope | |
Report Protection | Particulars |
Base yr | 2022 |
Historic interval | 2017-2021 |
Forecast interval | 2023-2027 |
Development momentum & CAGR | Speed up at a CAGR of 5.3% |
Market progress 2023-2027 | USD 3,394.36 million |
Market construction | Fragmented |
YoY progress 2022-2023 (%) | 4.21 |
Regional evaluation | North America, Europe, Asia, and the Remainder of the World (ROW) |
Performing market contribution | North America at 40% |
Key nations | US, Germany, UK, Japan, and China |
Aggressive panorama | Main Corporations, Market Positioning of Corporations, Aggressive Methods, and Business Dangers |
Key firms profiled | Abbott Laboratories, Alphatec Holdings Inc., B. Braun Melsungen AG, Bioventus LLC, Boston Scientific Corp., Exactech Inc., Globus Medical Inc., Implanet SA, Integra Lifesciences Holdings Corp., Johnson and Johnson Providers Inc., Kuros Biosciences AG, Medtronic Plc, Nuvasive Inc., Orthofix Medical Inc., RTI Surgical Inc., Backbone Wave Inc., Spineart SA, Stryker Corp., ulrich GmbH and Co. KG, and Xtant Medical Inc. |
Market dynamics | Mum or dad market evaluation, Market progress inducers and obstacles, Quick-growing and slow-growing phase evaluation, COVID-19 influence and restoration evaluation and future client dynamics, and Market situation evaluation for the forecast interval. |
Customization purview | If our report has not included the info that you’re on the lookout for, you’ll be able to attain out to our analysts and get segments custom-made. |
Desk of Contents
1 Govt Abstract
- 1.1 Market Overview
- Exhibit 01: Govt Abstract – Chart on Market Overview
- Exhibit 02: Govt Abstract – Knowledge Desk on Market Overview
- Exhibit 03: Govt Abstract – Chart on World Market Traits
- Exhibit 04: Govt Abstract – Chart on Market by Geography
- Exhibit 05: Govt Abstract – Chart on Market Segmentation by Sort
- Exhibit 06: Govt Abstract – Chart on Market Segmentation by Finish-user
- Exhibit 07: Govt Abstract – Chart on Incremental Development
- Exhibit 08: Govt Abstract – Knowledge Desk on Incremental Development
- Exhibit 09: Govt Abstract – Chart on Firm Market Positioning
2 Market Panorama
- 2.1 Market ecosystem
- Exhibit 10: Mum or dad market
- Exhibit 11: Market Traits
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Choices of firms included available in the market definition
- 3.2 Market phase evaluation
- Exhibit 13: Market segments
- 3.3 Market measurement 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on World – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 15: Knowledge Desk on World – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on World Market: Yr-over-year progress 2022-2027 (%)
- Exhibit 17: Knowledge Desk on World Market: Yr-over-year progress 2022-2027 (%)
4 Historic Market Dimension
- 4.1 World spinal implants and surgical units market 2017 – 2021
- Exhibit 18: Historic Market Dimension – Knowledge Desk on world spinal implants and surgical units market 2017 – 2021 ($ million)
- 4.2 Sort Phase Evaluation 2017 – 2021
- Exhibit 19: Historic Market Dimension – Sort Phase 2017 – 2021 ($ million)
- 4.3 Finish-user Phase Evaluation 2017 – 2021
- Exhibit 20: Historic Market Dimension – Finish-user Phase 2017 – 2021 ($ million)
- 4.4 Geography Phase Evaluation 2017 – 2021
- Exhibit 21: Historic Market Dimension – Geography Phase 2017 – 2021 ($ million)
- 4.5 Nation Phase Evaluation 2017 – 2021
- Exhibit 22: Historic Market Dimension – Nation Phase 2017 – 2021 ($ million)
5 5 Forces Evaluation
- 5.1 5 forces abstract
- Exhibit 23: 5 forces evaluation – Comparability between 2022 and 2027
- 5.2 Bargaining energy of patrons
- Exhibit 24: Chart on Bargaining energy of patrons – Affect of key components 2022 and 2027
- 5.3 Bargaining energy of suppliers
- Exhibit 25: Bargaining energy of suppliers – Affect of key components in 2022 and 2027
- 5.4 Menace of latest entrants
- Exhibit 26: Menace of latest entrants – Affect of key components in 2022 and 2027
- 5.5 Menace of substitutes
- Exhibit 27: Menace of substitutes – Affect of key components in 2022 and 2027
- 5.6 Menace of rivalry
- Exhibit 28: Menace of rivalry – Affect of key components in 2022 and 2027
- 5.7 Market situation
- Exhibit 29: Chart on Market situation – 5 forces 2022 and 2027
6 Market Segmentation by Sort
- 6.1 Market segments
- Exhibit 30: Chart on Sort – Market share 2022-2027 (%)
- Exhibit 31: Knowledge Desk on Sort – Market share 2022-2027 (%)
- 6.2 Comparability by Sort
- Exhibit 32: Chart on Comparability by Sort
- Exhibit 33: Knowledge Desk on Comparability by Sort
- 6.3 Open surgical procedures – Market measurement and forecast 2022-2027
- Exhibit 34: Chart on Open surgical procedures – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 35: Knowledge Desk on Open surgical procedures – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Open surgical procedures – Yr-over-year progress 2022-2027 (%)
- Exhibit 37: Knowledge Desk on Open surgical procedures – Yr-over-year progress 2022-2027 (%)
- 6.4 Minimally invasive surgical procedures – Market measurement and forecast 2022-2027
- Exhibit 38: Chart on Minimally invasive surgical procedures – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 39: Knowledge Desk on Minimally invasive surgical procedures – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Minimally invasive surgical procedures – Yr-over-year progress 2022-2027 (%)
- Exhibit 41: Knowledge Desk on Minimally invasive surgical procedures – Yr-over-year progress 2022-2027 (%)
- 6.5 Market alternative by Sort
- Exhibit 42: Market alternative by Sort ($ million)
- Exhibit 43: Knowledge Desk on Market alternative by Sort ($ million)
7 Market Segmentation by Finish-user
- 7.1 Market segments
- Exhibit 44: Chart on Finish-user – Market share 2022-2027 (%)
- Exhibit 45: Knowledge Desk on Finish-user – Market share 2022-2027 (%)
- 7.2 Comparability by Finish-user
- Exhibit 46: Chart on Comparability by Finish-user
- Exhibit 47: Knowledge Desk on Comparability by Finish-user
- 7.3 Hospitals – Market measurement and forecast 2022-2027
- Exhibit 48: Chart on Hospitals – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 49: Knowledge Desk on Hospitals – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 50: Chart on Hospitals – Yr-over-year progress 2022-2027 (%)
- Exhibit 51: Knowledge Desk on Hospitals – Yr-over-year progress 2022-2027 (%)
- 7.4 Ambulatory surgical facilities – Market measurement and forecast 2022-2027
- Exhibit 52: Chart on Ambulatory surgical facilities – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 53: Knowledge Desk on Ambulatory surgical facilities – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Ambulatory surgical facilities – Yr-over-year progress 2022-2027 (%)
- Exhibit 55: Knowledge Desk on Ambulatory surgical facilities – Yr-over-year progress 2022-2027 (%)
- 7.5 Specialty clinics – Market measurement and forecast 2022-2027
- Exhibit 56: Chart on Specialty clinics – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 57: Knowledge Desk on Specialty clinics – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on Specialty clinics – Yr-over-year progress 2022-2027 (%)
- Exhibit 59: Knowledge Desk on Specialty clinics – Yr-over-year progress 2022-2027 (%)
- 7.6 Market alternative by Finish-user
- Exhibit 60: Market alternative by Finish-user ($ million)
- Exhibit 61: Knowledge Desk on Market alternative by Finish-user ($ million)
8 Buyer Panorama
- 8.1 Buyer panorama overview
- Exhibit 62: Evaluation of value sensitivity, lifecycle, buyer buy basket, adoption charges, and buy standards
9 Geographic Panorama
- 9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2022-2027 (%)
- Exhibit 64: Knowledge Desk on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparability
- Exhibit 65: Chart on Geographic comparability
- Exhibit 66: Knowledge Desk on Geographic comparability
- 9.3 North America – Market measurement and forecast 2022-2027
- Exhibit 67: Chart on North America – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 68: Knowledge Desk on North America – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on North America – Yr-over-year progress 2022-2027 (%)
- Exhibit 70: Knowledge Desk on North America – Yr-over-year progress 2022-2027 (%)
- 9.4 Europe – Market measurement and forecast 2022-2027
- Exhibit 71: Chart on Europe – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 72: Knowledge Desk on Europe – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Europe – Yr-over-year progress 2022-2027 (%)
- Exhibit 74: Knowledge Desk on Europe – Yr-over-year progress 2022-2027 (%)
- 9.5 Asia – Market measurement and forecast 2022-2027
- Exhibit 75: Chart on Asia – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 76: Knowledge Desk on Asia – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on Asia – Yr-over-year progress 2022-2027 (%)
- Exhibit 78: Knowledge Desk on Asia – Yr-over-year progress 2022-2027 (%)
- 9.6 Remainder of World (ROW) – Market measurement and forecast 2022-2027
- Exhibit 79: Chart on Remainder of World (ROW) – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 80: Knowledge Desk on Remainder of World (ROW) – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on Remainder of World (ROW) – Yr-over-year progress 2022-2027 (%)
- Exhibit 82: Knowledge Desk on Remainder of World (ROW) – Yr-over-year progress 2022-2027 (%)
- 9.7 US – Market measurement and forecast 2022-2027
- Exhibit 83: Chart on US – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 84: Knowledge Desk on US – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on US – Yr-over-year progress 2022-2027 (%)
- Exhibit 86: Knowledge Desk on US – Yr-over-year progress 2022-2027 (%)
- 9.8 Germany – Market measurement and forecast 2022-2027
- Exhibit 87: Chart on Germany – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 88: Knowledge Desk on Germany – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on Germany – Yr-over-year progress 2022-2027 (%)
- Exhibit 90: Knowledge Desk on Germany – Yr-over-year progress 2022-2027 (%)
- 9.9 UK – Market measurement and forecast 2022-2027
- Exhibit 91: Chart on UK – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 92: Knowledge Desk on UK – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on UK – Yr-over-year progress 2022-2027 (%)
- Exhibit 94: Knowledge Desk on UK – Yr-over-year progress 2022-2027 (%)
- 9.10 Japan – Market measurement and forecast 2022-2027
- Exhibit 95: Chart on Japan – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 96: Knowledge Desk on Japan – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on Japan – Yr-over-year progress 2022-2027 (%)
- Exhibit 98: Knowledge Desk on Japan – Yr-over-year progress 2022-2027 (%)
- 9.11 China – Market measurement and forecast 2022-2027
- Exhibit 99: Chart on China – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 100: Knowledge Desk on China – Market measurement and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on China – Yr-over-year progress 2022-2027 (%)
- Exhibit 102: Knowledge Desk on China – Yr-over-year progress 2022-2027 (%)
- 9.12 Market alternative by geography
- Exhibit 103: Market alternative by geography ($ million)
- Exhibit 104: Knowledge Tables on Market alternative by geography ($ million)
10 Drivers, Challenges, and Traits
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Affect of drivers and challenges
- Exhibit 105: Affect of drivers and challenges in 2022 and 2027
- 10.4 Market tendencies
11 Firm Panorama
- 11.1 Overview
- 11.2 Vendor panorama
- Exhibit 106: Overview on Criticality of inputs and Components of differentiation
- 11.3 Panorama disruption
- Exhibit 107: Overview on components of disruption
- 11.4 Business dangers
- Exhibit 108: Affect of key dangers on enterprise
12 Vendor Evaluation
- 12.1 Corporations lined
- Exhibit 109: Corporations lined
- 12.2 Market positioning of Corporations
- Exhibit 110: Matrix on vendor place and classification
- 12.3 Abbott Laboratories
- Exhibit 111: Abbott Laboratories – Overview
- Exhibit 112: Abbott Laboratories – Enterprise segments
- Exhibit 113: Abbott Laboratories – Key information
- Exhibit 114: Abbott Laboratories – Key choices
- Exhibit 115: Abbott Laboratories – Phase focus
- 12.4 Alphatec Holdings Inc.
- Exhibit 116: Alphatec Holdings Inc. – Overview
- Exhibit 117: Alphatec Holdings Inc. – Product / Service
- Exhibit 118: Alphatec Holdings Inc. – Key choices
- 12.5 B. Braun Melsungen AG
- Exhibit 119: B. Braun Melsungen AG – Overview
- Exhibit 120: B. Braun Melsungen AG – Enterprise segments
- Exhibit 121: B. Braun Melsungen AG – Key information
- Exhibit 122: B. Braun Melsungen AG – Key choices
- Exhibit 123: B. Braun Melsungen AG – Phase focus
- 12.6 Bioventus LLC
- Exhibit 124: Bioventus LLC – Overview
- Exhibit 125: Bioventus LLC – Enterprise segments
- Exhibit 126: Bioventus LLC – Key information
- Exhibit 127: Bioventus LLC – Key choices
- Exhibit 128: Bioventus LLC – Phase focus
- 12.7 Boston Scientific Corp.
- Exhibit 129: Boston Scientific Corp. – Overview
- Exhibit 130: Boston Scientific Corp. – Enterprise segments
- Exhibit 131: Boston Scientific Corp. – Key information
- Exhibit 132: Boston Scientific Corp. – Key choices
- Exhibit 133: Boston Scientific Corp. – Phase focus
- 12.8 Globus Medical Inc.
- Exhibit 134: Globus Medical Inc. – Overview
- Exhibit 135: Globus Medical Inc. – Product / Service
- Exhibit 136: Globus Medical Inc. – Key choices
- 12.9 Integra Lifesciences Holdings Corp.
- Exhibit 137: Integra Lifesciences Holdings Corp. – Overview
- Exhibit 138: Integra Lifesciences Holdings Corp. – Enterprise segments
- Exhibit 139: Integra Lifesciences Holdings Corp. – Key information
- Exhibit 140: Integra Lifesciences Holdings Corp. – Key choices
- Exhibit 141: Integra Lifesciences Holdings Corp. – Phase focus
- 12.10 Johnson and Johnson Providers Inc.
- Exhibit 142: Johnson and Johnson Providers Inc. – Overview
- Exhibit 143: Johnson and Johnson Providers Inc. – Enterprise segments
- Exhibit 144: Johnson and Johnson Providers Inc. – Key information
- Exhibit 145: Johnson and Johnson Providers Inc. – Key choices
- Exhibit 146: Johnson and Johnson Providers Inc. – Phase focus
- 12.11 Medtronic Plc
- Exhibit 147: Medtronic Plc – Overview
- Exhibit 148: Medtronic Plc – Enterprise segments
- Exhibit 149: Medtronic Plc – Key information
- Exhibit 150: Medtronic Plc – Key choices
- Exhibit 151: Medtronic Plc – Phase focus
- 12.12 Nuvasive Inc.
- Exhibit 152: Nuvasive Inc. – Overview
- Exhibit 153: Nuvasive Inc. – Enterprise segments
- Exhibit 154: Nuvasive Inc. – Key information
- Exhibit 155: Nuvasive Inc. – Key choices
- Exhibit 156: Nuvasive Inc. – Phase focus
- 12.13 Orthofix Medical Inc.
- Exhibit 157: Orthofix Medical Inc. – Overview
- Exhibit 158: Orthofix Medical Inc. – Enterprise segments
- Exhibit 159: Orthofix Medical Inc. – Key choices
- Exhibit 160: Orthofix Medical Inc. – Phase focus
- 12.14 RTI Surgical Inc.
- Exhibit 161: RTI Surgical Inc. – Overview
- Exhibit 162: RTI Surgical Inc. – Product / Service
- Exhibit 163: RTI Surgical Inc. – Key choices
- 12.15 Spineart SA
- Exhibit 164: Spineart SA – Overview
- Exhibit 165: Spineart SA – Product / Service
- Exhibit 166: Spineart SA – Key choices
- 12.16 Stryker Corp.
- Exhibit 167: Stryker Corp. – Overview
- Exhibit 168: Stryker Corp. – Enterprise segments
- Exhibit 169: Stryker Corp. – Key information
- Exhibit 170: Stryker Corp. – Key choices
- Exhibit 171: Stryker Corp. – Phase focus
- 12.17 ulrich GmbH and Co. KG
- Exhibit 172: ulrich GmbH and Co. KG – Overview
- Exhibit 173: ulrich GmbH and Co. KG – Product / Service
- Exhibit 174: ulrich GmbH and Co. KG – Key choices
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions guidelines
- Exhibit 175: Inclusions guidelines
- Exhibit 176: Exclusions guidelines
- 13.3 Forex conversion charges for US$
- Exhibit 177: Forex conversion charges for US$
- 13.4 Analysis methodology
- Exhibit 178: Analysis methodology
- Exhibit 179: Validation methods employed for market sizing
- Exhibit 180: Info sources
- 13.5 Listing of abbreviations
- Exhibit 181: Listing of abbreviations
About Us
Technavio is a number one world know-how analysis and advisory firm. Their analysis and evaluation deal with rising market tendencies and supply actionable insights to assist companies establish market alternatives and develop efficient methods to optimize their market positions. With over 500 specialised analysts, Technavio’s report library consists of greater than 17,000 experiences and counting, masking 800 applied sciences, spanning 50 nations. Their consumer base consists of enterprises of all sizes, together with greater than 100 Fortune 500 firms. This rising consumer base depends on Technavio’s complete protection, in depth analysis, and actionable market insights to establish alternatives in current and potential markets and assess their aggressive positions inside altering market eventualities.
Contact
Technavio Analysis
Jesse Maida
Media & Advertising and marketing Govt
US: +1 844 364 1100
UK: +44 203 893 3200
E-mail: media@technavio.com
Web site: www.technavio.com
SOURCE Technavio
Discussion about this post